Kevin B. Jones,
MD
Languages Spoken: English, Spanish
Labs: Website
Kevin B. Jones, MD
Leader, Huntsman Cancer Institute Sarcoma Disease Center
Division Chief, Sarcoma, Department of Orthopaedics
Professor, Department of Orthopaedics and
Adjunct Professor of Oncological Sciences
As an orthopaedic surgeon specialized in the care of pediatric and adult patients with sarcoma, I see first-hand the limitations and frank failures of the currently available treatment options. Not only do we fail to cure far too many young patients with sarcomas, but the long-term effects of our treatments create other major challenges to the health of the survivors in the long term.
With protected time for basic investigation, I dedicate my entire laboratory to the study of pediatric and young adult fusion oncogene-associated sarcomas. In efforts always angling toward improved targeted therapies, we use mouse genetic models of sarcomagenesis to dissect pathways of importance to initiation and progression of tumors. This work utilizes conditional activation of translocation-associated fusion oncogenes as well as manipulation of additional modifying genes directed toward improved understanding of the conditions that promote or inhibit sarcomagenesis. This work has led to generous experience with comparative genomics and epigenomics.
The simple genetic changes that drive translocation-associated sarcomas make a strong argument for cancer being defined as a transcriptional state for cells, rather than a state of accumulated mutations or genetic losses and gains. The study of the epigenetic determinants of this transcriptional state in cells that harbor very few genetic code alterations has already revealed important knowledge that pertains to more complex genome cancer types as well as to transcriptional biology more generally.
I also believe firmly in the synergy possible in collaborative team science. Such efforts are required for progress toward improved treatments for rare malignancies that can never be studied with optimal efficacy in a silo. With such collaborative work as direct goal, I have participated in and assembled teams to work on pediatric sarcomas both within my institution and internationally.
Clinical Locations
Clinic 3A, Sarcoma
801-585-7180
Fax: (801) 213-6046
Primary Children's Hospital
Pediatric Orthopaedics801-662-5600
Fax: (801) 662-5630
Board Certification and Academic Information
| Academic Departments | Orthopaedics
-
Professor Oncological Sciences - Adjunct Professor |
| Board Certification | American Board of Orthopaedic Surgery |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.3/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
May 14, 2022
HUNTSMAN CANCER CENTER
I always feel very well attended to by Dr Jones and his fellows
UofU Patient
April 30, 2022
HUNTSMAN CANCER CENTER
Both Dr Jones and assistant Dr ----haus, were knowledgeable, caring/concerned...awesome!
UofU Patient
April 30, 2022
HUNTSMAN CANCER CENTER
I would recommend the hospital, staff and doctors to anyone facing similar conditions.
UofU Patient
April 15, 2022
HUNTSMAN CANCER CENTER
Dr. Jones was great. Very smart. Explained my condition in detail and discussed options.
UofU Patient
April 08, 2022
HUNTSMAN CANCER CENTER
Dr Kevin Jones was excellent!
UofU Patient
April 07, 2022
HUNTSMAN CANCER CENTER
Dr. Jones has been incredibly diligent to help solve my complex healthcare issues. I would definitely recommend him for your healthcare needs.
UofU Patient
March 24, 2022
HUNTSMAN CANCER CENTER
Dr. Jones is great at listening to you and discussing my concerns
UofU Patient
March 19, 2022
HUNTSMAN CANCER CENTER
Dr. Jones was excellent as always.
UofU Patient
February 17, 2022
HUNTSMAN CANCER CENTER
This was a follow up visit about six weeks after surgery on hip.
UofU Patient
February 06, 2022
HUNTSMAN CANCER CENTER
Dr. Jones explained my situation carefully and honestly and allowed time for all of my questions.
UofU Patient
January 30, 2022
HUNTSMAN CANCER CENTER
I can not Think more highly ofOr recommend enoughDr. JONES.Dr. JONES had exceeded my expectations in every way!
UofU Patient
January 16, 2022
HUNTSMAN CANCER CENTER
Good
UofU Patient
January 02, 2022
HUNTSMAN CANCER CENTER
I had a very good experience at my appointment.
UofU Patient
December 17, 2021
HUNTSMAN CANCER CENTER
I was very happy with Dr Jjones
UofU Patient
December 09, 2021
HUNTSMAN CANCER CENTER
Everyone listened to my questions and gave understandable feedback.
UofU Patient
November 28, 2021
HUNTSMAN CANCER CENTER
Any questions I had were answered promptly and with patience. They took the time to make sure that I felt comfortable with any procedures.
UofU Patient
November 19, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
He don't seem to understand or value our concerns, almost like he don't really know what to do so end result is always so frustrating.
UofU Patient
November 12, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
The doctor and Intern were very friendly and addressed our concerns once they came into the room.
UofU Patient
November 04, 2021
HUNTSMAN CANCER CENTER
Dr. Jones always makes me feel like I am his only patient and he has all the time in the world to answer questions and concerns and get to know me. I feel seen, heard and taken care of on every level. I am very grateful for all the support and outcome.
UofU Patient
October 21, 2021
HUNTSMAN CANCER CENTER
Other appts have been great. Just felt rushed after waiting so long to get in
UofU Patient
October 14, 2021
HUNTSMAN CANCER CENTER
I felt that they had all the time just for me!
UofU Patient
October 13, 2021
HUNTSMAN CANCER CENTER
Very informative and never felt rushed.
UofU Patient
August 19, 2021
HUNTSMAN CANCER CENTER
Dr. Jones was very good at explaining my condition and the treatment plan for now.
UofU Patient
August 12, 2021
HUNTSMAN CANCER CENTER
Explained everything very well, took time to make sure I understood the process and answered my question.
UofU Patient
August 02, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
Dr. Jones was very thorough and made us feel much more at ease, we were very pleased.
UofU Patient
July 29, 2021
HUNTSMAN CANCER CENTER
Dr. Jones is the best doctor in the universe. :)
UofU Patient
July 23, 2021
HUNTSMAN CANCER CENTER
I was impressed with the medical team led by Doctor Kevin Jones that performed the biopsy on my thigh. They were concerned about my mental state of mind and the level of pain I was experiencing. They explained what was going to take place and then explained things in more detail as they performed the biopsy. They also let me know when to expect the results. My thigh is recovering just fine.
UofU Patient
July 22, 2021
HUNTSMAN CANCER CENTER
Medical staff were all great. Very attentive.
UofU Patient
July 22, 2021
HUNTSMAN CANCER CENTER
So caring, knowledgable, and thorough.
UofU Patient
July 19, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
Doctor Jones is amazing and always explains everything thoroughly, listens to questions and concerns and takes the time to careful answer!
UofU Patient
July 17, 2021
HUNTSMAN CANCER CENTER
Dr Jones was "the man". I was very impressed by his knowledge and manner. I went into surgery with total confidence in him.
UofU Patient
April 21, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
My son was there to talk with his orthopedic surgeon about my son's desire to amputate his left leg due to ongoing, progressive medical issues both in the bone and surrounding tumor. Dr Jones listened to my son talk about his desire, answered my son's questions fully, and explained to my son the surgery and the recovery. My son wants his leg to be used for research for his condition and his main specialist was in attendance as well. The way these doctors work together with my son is the example of how medical should be. We are ever thankful for Dr Jones.
UofU Patient
April 19, 2021
HUNTSMAN CANCER CENTER
Dr. Jones is my super hero. He has been so amazing during my journey. I contribute my amazing results to him.
UofU Patient
March 16, 2021
HUNTSMAN CANCER CENTER
So thankful for the followup care U of U and Dr. Kevin Jones team is providing. Having their expertise along with local care team gives me reassurance and some semblance of calm
UofU Patient
February 28, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
Dr. Jones said, "You are paying me to worry about this now for your son, so you don't have to." I loved hearing that. What a great way to explain his role. It showed confidence and compassion.
UofU Patient
February 26, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
Dr.Kevin Jones has really been willing to listen to our son's needs and help him with decision making and give knowledgeable information. We have really liked him and believe he cares about his patients.
UofU Patient
February 25, 2021
HUNTSMAN CANCER CENTER
very good visit. very informative. everyone took extra time to make me feel at ease and comfortable with my treatment. thank you
UofU Patient
February 14, 2021
HUNTSMAN CANCER CENTER
Dr. Kevin and Teamthank you for your life's work serving others!
UofU Patient
February 04, 2021
HUNTSMAN CANCER CENTER
1 year follow up appt and Dr Jones saved my leg and my long term mobility. I cannot thank him and his staff enough.
UofU Patient
February 04, 2021
HUNTSMAN CANCER CENTER
This is by far one of the best medical facilities I have been too.
UofU Patient
January 28, 2021
HUNTSMAN CANCER CENTER
doctor was willing to be candid about situation. discussed non traditional options
UofU Patient
January 28, 2021
HUNTSMAN CANCER CENTER
I highly reccomend Dr Jones and his staff. He always has fellow working with him and they have been excellent.
UofU Patient
January 22, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
Dr. Jones is amazing. He was great at helping my child feel comfortable and I am confident in my child's care.
UofU Patient
January 14, 2021
HUNTSMAN CANCER CENTER
Dr Jones was thorough, he showed us the xrays where [NAME REMOVED]'s hip was shattered and explained it so we knew what he was up against. he did not push [NAME REMOVED] to have surgery. the risk is too great.
UofU Patient
January 14, 2021
HUNTSMAN CANCER CENTER
I felt all questions were answered and next steps provided in an atmosphere of true caring and competency
UofU Patient
January 06, 2021
PRIMARY CHILDREN'S MEDICAL CENTER
Dr Jones listened to my son when my son said the cast that was just placed wasn't fitting correctly. He knows my son and involves my son in the medical plan.
UofU Patient
December 10, 2020
PRIMARY CHILDREN'S MEDICAL CENTER
Dr Jones is incredible! He has a great relationship with my son and our family. My son has had some challenging orthopedic issues and my son knows Dr Jones has his (my son's) best outcome in mind.
UofU Patient
December 04, 2020
HUNTSMAN CANCER CENTER
Excellent doctor! Professional and compassionate.
UofU Patient
December 02, 2020
PRIMARY CHILDREN'S MEDICAL CENTER
Very caring and thorough.
UofU Patient
October 25, 2020
HUNTSMAN CANCER CENTER
Great people
Kevin B. Jones, MD
Leader, Huntsman Cancer Institute Sarcoma Disease Center
Division Chief, Sarcoma, Department of Orthopaedics
Professor, Department of Orthopaedics and
Adjunct Professor of Oncological Sciences
As an orthopaedic surgeon specialized in the care of pediatric and adult patients with sarcoma, I see first-hand the limitations and frank failures of the currently available treatment options. Not only do we fail to cure far too many young patients with sarcomas, but the long-term effects of our treatments create other major challenges to the health of the survivors in the long term.
With protected time for basic investigation, I dedicate my entire laboratory to the study of pediatric and young adult fusion oncogene-associated sarcomas. In efforts always angling toward improved targeted therapies, we use mouse genetic models of sarcomagenesis to dissect pathways of importance to initiation and progression of tumors. This work utilizes conditional activation of translocation-associated fusion oncogenes as well as manipulation of additional modifying genes directed toward improved understanding of the conditions that promote or inhibit sarcomagenesis. This work has led to generous experience with comparative genomics and epigenomics.
The simple genetic changes that drive translocation-associated sarcomas make a strong argument for cancer being defined as a transcriptional state for cells, rather than a state of accumulated mutations or genetic losses and gains. The study of the epigenetic determinants of this transcriptional state in cells that harbor very few genetic code alterations has already revealed important knowledge that pertains to more complex genome cancer types as well as to transcriptional biology more generally.
I also believe firmly in the synergy possible in collaborative team science. Such efforts are required for progress toward improved treatments for rare malignancies that can never be studied with optimal efficacy in a silo. With such collaborative work as direct goal, I have participated in and assembled teams to work on pediatric sarcomas both within my institution and internationally.
Academic Locations
Research Statement
With 80 percent protected time for academic pursuits, and an independent laboratory at the Huntsman Cancer Institute, I focus most of my research on dissecting the genetic and epigenetic underpinnings of sarcoma initiation. Although sarcomas are rare cancers, the tissues which give rise to sarcomas when they become cancerous are the predominant tissues in the human body, the muscles, tendons, bones, vessels, fat, etc. These tissues derive from mesenchyme or mesoderm. While many organ-based cancer cells gain some characteristics of mesenchyme or mesoderm as they become malignant, turning mesenchyme itself into cancer is much more difficult. The intrinsic resistance to transformation (the process of becoming cancerous) in mesenchyme has brought particular focus to any factor capable of overcoming that resistance and forming cancers from connective tissues.Thus, sarcomas--not only in spite of, but actually because of their low frequency in the general population--have played a central role in the fundamental discoveries of cancer biology. For example, radium dial painters developing osteosarcomas led to the discovery that radiation causes cancer. Oncogenes, the tumor causing genes, were discovered by study of a virus that caused sarcomas in birds. Tumor suppressor genes, the genes that when turned off lead to cancer, were discovered because families had too many sarcomas (Even two is way too common in any one family!) We therefore pursue sarcoma biology vigorously not only because we need to generate better treatment strategies for this horrible group of cancers that impacts young people disproportionately, but also because sarcoma will likely yet teach us much more about cancer biology in general, especially its beginnings.
Board Certification and Academic Information
| Academic Departments | Orthopaedics
-
Professor Oncological Sciences - Adjunct Professor |
| Board Certification | American Board of Orthopaedic Surgery |
Research Interests
- Sarcoma, Synovial
- Osteosarcoma
- Mouse Models
- Ewing's Sarcoma
- Chondrosarcoma
- Sarcoma
- Soft Tissue Sarcomas
- Sarcoma, Clear Cell
Education History
| Other Training | Mario Capecchi Laboratory, University of Utah Mentored Scientific Training-Mouse Genetic Modeling of Sarcoma , 2013 |
| Fellowship | Mount Sinai Hospital Musculoskeletal Oncology Fellow, 2008 |
| Residency | University of Iowa Hospitals and Clinics Orthopaedic Surgery Resident, 2007 |
| Professional Medical | Johns Hopkins University Medicine M.D., 2002 |
| Undergraduate | Harvard University English and American Literature and Language A.B., 1998 |
Selected Publications - Journal Articles
Journal Article
- Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer Causes Control, 33(7), 939-950.
- Pires G, Moss WD, Luo J, Zhang R, Jones KB, Kwok AC, Agarwal JP (2022). Free Vascularized Fibula Salvage of Failed CPH in Pediatric Sarcoma Patients. Sarcoma, 2022, 6240293.
- Brashears CB, Prudner BC, Rathore R, Caldwell KE, Dehner CA, Buchanan JL, Lange SES, Poulin N, Sehn JK, Roszik J, Spitzer D, Jones KB, OKeefe RJ, Nielsen TO, Taylor EB, Held JM, Hawkins W, Van Tine BA (2022). Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT3102. Clin Cancer Res.
- Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health.
- Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250.
- Brown JM, Rakoczy K, Hart J, Jones KB, Groundland JS (2022). Presenting features and overall survival of chondrosarcoma of the pelvis. Cancer Treat Res Commun, 30, 100510.
- Groundland J, Brown JM, Monument M, Bernthal N, Jones KB, Randall RL (2021). What Are the Long-term Surgical Outcomes of Compressive Endoprosthetic Osseointegration of the Femur with a Minimum 10-year Follow-up Period? Clin Orthop Relat Res, 480, 539-548.
- Kraus RD, Weil CR, Wells S, Tward JD, Groundland JS, Jones KB, Cannon DM (2021). Radiation Therapy in Conjunction With Surgical Stabilization of Impending or Pathologic Fractures Secondary to Metastasis: Is There a Difference Between Single and Multifraction Regimens? Adv Radiat Oncol, 7(2), 100795.
- Kim SK, Nguyen C, Jones KB, Tashjian RZ (2021). A genome-wide association study for shoulder impingement and rotator cuff disease. J Shoulder Elbow Surg, 30(9), 2134-2145.
- Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Bove JVMG, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Lim J, Chirlaque Lpez MD, Maestro R, Marcos-Gragera R, Martin Broto J, Matsuda T, Mir O, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Sundby Hall K, Tap WD, Thomas DM, van der Graaf WTA, van Houdt WJ, Visser O, von Mehren M, Wagner AJ, Wilky BA, Won YJ, Fletcher CDM, Dei Tos AP, Trama A (2021). Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer, 127(16), 2934-2942.
- Panza E, Ozenberger BB, Straessler KM, Barrott JJ, Li L, Wang Y, Xie M, Boulet A, Titen SW, Mason CC, Lazar AJ, Ding L, Capecchi MR, Jones KB (2020). The clear cell sarcoma functional genomic landscape. J Clin Invest, 131(15).
- Kannan S, Lock I, Ozenberger BB, Jones KB (2021). Genetic drivers and cells of origin in sarcomagenesis. J Pathol, 254(4), 474-493.
- Groundland J, Brown J, Jones K, Randall RL (2021). Is osseous reattachment of the greater trochanter necessary compared to soft-tissue-only abductor repair in proximal femoral megaprosthesis reconstruction? J Surg Oncol, 124(1), 115-123.
- Li J, Mulvihill TS, Li L, Barrott JJ, Nelson ML, Wagner L, Lock IC, Pozner A, Lambert SL, Ozenberger BB, Ward MB, Grossmann AH, Liu T, Banito A, Cairns BR, Jones KB (2021). A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction. Cancer Discov, 11(10), 2620-2637.
- Tashjian RZ, Kim SK, Roche MD, Jones KB, Teerlink CC (2020). Genetic variants associated with rotator cuff tearing utilizing multiple population-based genetic resources. J Shoulder Elbow Surg, 30(3), 520-531.
- Schneider P, Giglio V, Ghanem D, Wilson D, Turcotte R, Isler M, Mottard S, Miller B, Hayden J, Doung YC, Gundle K, Randall RL, Jones K, Vlez R, Ghert M (2021). Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey. BMJ Open, 11(2), e042742.
- Kim J, Light N, Subasri V, Young EL, Wegman-Ostrosky T, Barkauskas DA, Hall D, Lupo PJ, Patidar R, Maese LD, Jones K, Wang M, Tavtigian SV, Wu D, Shlien A, Telfer F, Goldenberg A, Skapek SX, Wei JS, Wen X, Catchpoole D, Hawkins DS, Schiffman JD, Khan J, Malkin D, Stewart DR (2021). Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO Precis Oncol, 5.
- Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, Ladanyi M, Nielsen TO (2020). The epigenomics of sarcoma. Nat Rev Cancer, 20(10), 608-623.
- Tashjian RZ, Lock I, Granger EK, Wang Y, Lee Y, Chalmers PN, Jones KB (2020). Gene Expression in Torn Rotator Cuff Tendons Determined by RNA Sequencing. Orthop J Sports Med, 8(6), 2325967120927480.
- Blank AT, Larson BM, Shaw S, Wakefield CJ, King T, Jones KB, Randall RL (2020). National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review. World J Clin Oncol, 11(6), 389-396.
- Lambert SL, Jones KB (2020). SKP2 My Lou, My Darling. Cancer Res, 80(12), 2437-2438.
- Kirkham M, Kalivas A, Fatema K, Luelling S, Dubansky BH, Dubansky B, Jones KB, Barrott JJ (2020). Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma. Int J Mol Sci, 21(7).
- Miller DT, Corts-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, Piculell K, Al-Ibraheemi A, Dickson BC, Hart J, Jones K, Jordan JT, Kim RH, Lindsay D, Nishida Y, Ullrich NJ, Wang X, Park PJ, Flanagan AM (2020). Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes (Basel), 11(4).
- Blank AT, Shaw S, Wakefield CJ, Zhang Y, Liu WJ, Jones KB, Randall RL (2019). What factors influence patient experience in orthopedic oncology office visits? World J Clin Oncol, 11(3), 136-142.
- Abbott D, OBrien S, Farnham JM, Young EL, Yap J, Jones K, Lessnick SL, Randall RL, Schiffman JD, Cannon-Albright LA (2019). Increased risk for other cancers in individuals with Ewing sarcoma and their relatives. Cancer Med, 8(18), 7924-7930.
- Jones KB (2019). Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor. Cancer Discov, 9(11), 1484-1486.
- Goodwin ML, Gundavda MK, Reddy R, Deogaonkar K, Lala M, Baliarsing A, Sciubba DM, Jones KB, Agarwal M (2019). Extracorporeal radiation and reimplantation: a safe and viable option for reconstruction after sacral tumor resection? Ann Transl Med, 7(10), 229.
- Barrott JJ, Illum BE, Jin H, Hedberg ML, Wang Y, Grossmann A, Haldar M, Capecchi MR, Jones KB (2018). Paracrine osteoprotegerin and beta-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest, 128(1), 207-218.
- Kwok AC, Tatro E, Jones KB, Agarwal JP (2017). Pedicled Retrograde Fibula Flap for Ankle Reconstruction after Oncologic Resection of the Distal Fibula. Plast Reconstr Surg Glob Open, 5(2), e1232.
- Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB (2016). Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med, 213(13), 2989-3005.
- Jones KB, Barrott JJ, Xie M, Haldar M, Jin H, Zhu JF, Monument MJ, Mosbruger TL, Langer EM, Randall RL, Wilson RK, Cairns BR, Ding L, Capecchi MR (2016). The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis. Oncogene, 35(38), 5021-32.
- Barrott JJ, Illum BE, Jin H, Zhu JF, Mosbruger T, Monument MJ, Smith-Fry K, Cable MG, Wang Y, Grossmann AH, Capecchi MR, Jones KB (2015). beta-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition. Oncotarget, 6(26), 22758-66.
- Quist T, Jin H, Zhu JF, Smith-Fry K, Capecchi MR, Jones KB (2015). The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse. Oncogene, 34(32), 4278-84.
- de Andrea CE, Zhu JF, Jin H, Bovee JV, Jones KB (2015). Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency. J Pathol, 236(2), 210-8.
- Monument MJ, Bernthal NM, Bowles AJ, Jones KB, Randall RL (2015). What are the 5-year survivorship outcomes of compressive endoprosthetic osseointegration fixation of the femur? Clin Orthop Relat Res, 473(3), 883-90.
- Goodwin ML, Jin H, Straessler K, Smith-Fry K, Zhu JF, Monument MJ, Grossmann A, Randall RL, Capecchi MR, Jones KB (2014). Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment. Cancer Cell, 26(6), 851-862.
- Jones KB, Su L, Jin H, Lenz C, Randall RL, Underhill TM, Nielsen TO, Sharma S, Capecchi MR (2013). SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas. Oncogene, 32(18), 2365-71, 2375.e1-5.
- Jones KB, Datar M, Ravichandran S, Jin H, Jurrus E, Whitaker R, Capecchi MR (2013). Toward an understanding of the short bone phenotype associated with multiple osteochondromas. J Orthop Res, 31(4), 651-7.
- Straessler KM, Jones KB, Hu H, Jin H, van de Rijn M, Capecchi MR (2013). Modeling clear cell sarcomagenesis in the mouse: cell of origin differentiation state impacts tumor characteristics. Cancer Cell, 23(2), 215-27.
- Jones KB, Ferguson PC, Lam B, Biau DJ, Hopyan S, Deheshi B, Griffin AM, White LM, Wunder JS (2012). Effects of neoadjuvant chemotherapy on image-directed planning of surgical resection for distal femoral osteosarcoma. J Bone Joint Surg Am, 94(15), 1399-405.
- Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI (2012). miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res, 72(7), 1865-77.
- Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Ageilan RI (04/01/2012). miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res, 72(7), 1865-77.
- Su L, Sampaio AV, Jones KB, Pacheco M, Goytain A, Lin S, Poulin N, Yi L, Rossi FM, Kast J, Capecchi MR, Underhill TM, Nielsen TO (2012). Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer Cell, 21(3), 333-47.
- Jones KB, Schiffman JD, Kohlmann W, Randall RL, Lessnick SL, Cannon-Albright LA (2011). Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer Epidemiol Biomarkers Prev, 20(5), 751-7.
- Israelsen RB, Illum BE, Crabtree S, Randall RL, Jones KB (2011). Extremity sarcoma surgery in younger children: ten years of patients ten years and under. Iowa Orthop J, 31, 145-53.
- Jones KB, Piombo V, Searby C, Kurriger G, Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA, Capecchi MR, Vortkamp A, Sheffield VC (2010). A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci U S A, 107(5), 2054-9.
- Jones KB (2007). Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones [Skeletal Lesion Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group ]. J Bone Joint Surg Am, 89(10), 2113-2123.
- Jones KB, Buckwalter JA, Frassica FJ, McCarthy EF (2005). Intracortical chondroma: a report of two cases. Skeletal Radiol, 35(5), 298-301.
Case Report
- Abbasi AM, Hosein RC, Willis RN Jr, Lelkes VM, Jones KB, Agarwal JP (2020). Modified Rotationplasty as a Composite Free Flap for Femur and Thigh Reconstruction. World J Plast Surg, 10(2), 115-119.
- Serpico R, Brown J, Blank A, Jones K, Randall RL, Groundland J (2021). Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature. Case Rep Oncol, 14(1), 647-658.
- Blank AT, Wakefield C, Khalighi M, Jones KB, Randall RL (2020). Epithelioid Osteoblastoma of the Proximal Femur in a 19-Year-Old Female: A Case Report and Review of Literature. J Orthop Case Rep, 9(5), 74-77.
Other
Global Impact
Education History
| Fellowship | Mount Sinai Hospital Musculoskeletal Oncology Fellow |